asthma in pregnancy
in review
2 min read
Updated 2026-10-27
asthma in pregnancy
Treat as in non-pregnancy — uncontrolled asthma (maternal hypoxaemia) harms the foetus more than any controller. Don’t stop or step down ICS; don’t withhold prednisone in exacerbations. PaCO₂ normal for non-pregnant (~40 mmHg) = loss of expected hypocapnia in pregnancy — a tiring patient; read with pH. Peripartum: stress-dose steroids if recent systemic steroids; avoid carboprost for PPH.
course and risk
- Roughly a third each improve, stay the same, worsen; exacerbations peak late T2
- Poor control → preeclampsia, preterm birth, FGR, low birth weight
- Pregnancy doesn’t cause airflow obstruction — ↓FEV₁ is asthma, not pregnancy
- Physiological dyspnoea: early onset, non-progressive, normal SpO₂/spirometry, no wheeze
- Review control each visit; written action plan; treat rhinitis, GERD; smoking cessation; inactivated flu, COVID, RSV, Tdap vaccines
controller therapy
| agent | pregnancy |
|---|---|
| ICS (budesonide most data) | continue — don’t switch a well-controlled patient to budesonide |
| ICS–formoterol (MART) | continue/start as per GINA |
| ICS–LABA (salmeterol, vilanterol) | continue |
| SABA | rescue; frequent use = poor control |
| LTRA (montelukast) | continue if previously effective |
| LAMA (tiotropium) | limited data; continue if needed |
| biologics (omalizumab most data; mepolizumab, benralizumab, dupilumab) | generally continue in severe asthma — IgG transfer ↑ in T3; see asthma biologics |
| theophylline | avoid starting (narrow window, clearance changes) |
- No LABA monotherapy
- Oral prednisone short courses acceptable; small signals (cleft lip, preeclampsia) are outweighed by exacerbation risk
acute exacerbation
- Severity: SpO₂ target ≥95%, PEF, work of breathing; foetal monitoring if ≥24 wk
- Salbutamol ± ipratropium; prednisone 40–50 mg × 5–7 d (or IV methylprednisolone)
- Severe/refractory: IV MgSO₄ 2 g over 20 min; ICU early
- ABG: pH 7.40–7.47, PaCO₂ 28–32 mmHg normally → PaCO₂ ≥35–40 mmHg = loss of expected hypocapnia (inadequate ventilation)
- Intubation: difficult airway, rapid desaturation (↓FRC) — most experienced operator; left uterine displacement
- New breathlessness not fitting asthma → PE, pneumonia, PPCM, pulmonary oedema
blood gas in pregnant asthmatic
Breathless asthmatic at 30 wk with PaCO₂ 40 mmHg and pH 7.38 — a “normal” gas with acidaemia and distress = impending respiratory failure. Escalate now.
labour and postpartum
- Continue all controllers and SABA in labour; exacerbations in labour are uncommon
- Stress-dose hydrocortisone in labour/CS if systemic steroids >2–3 wk in the prior ~6 months (adrenal suppression)
- PPH uterotonics: oxytocin, misoprostol, ergometrine (caution — HTN) acceptable; carboprost (15-methyl PGF₂α) → bronchospasm — avoid
- Labetalol for HTN: caution in asthma → prefer nifedipine
- NSAID-exacerbated respiratory disease: avoid NSAIDs postpartum
- Breastfeeding: all inhaled agents, montelukast, prednisone compatible
Prepared 2026-10-27. Not yet verified — check every number against the sources.